Etiometry Expands Leadership with New CEO

BOSTON, November 7th, 2019 – Etiometry Inc., a leading digital health company which developed a critical care analytics platform, announced today the recent expansion of their leadership team.

Shane Cooke was recently appointed as President and Chief Executive Officer, joining the growing company as it continues to expand its presence in current and new markets. Cooke brings more than 19 years of experience in the medical device and pharmaceutical market spaces in a variety of sales, marketing, strategy, and portfolio management roles. Before joining Etiometry, Cooke spent more than five years as Chief Strategy Officer of Cheetah Medical, which was recently acquired.

“I am excited to join Etiometry, whose best-in-class technology is already utilized in top pediatric hospitals throughout the world” said Cooke. “This technology platform has massive market potential, and I look forward to accelerating growth and realizing the company’s vision of improving outcomes and avoiding patient harm.”

In recent months, Etiometry also expanded their Board of Directors to include Guy Lyndon Fish MD, Gregory S. Martin, CEO and President of Shamrock Holdings, and David Shepherd, co-CEO of Shepherd Kaplan Krochuk.

Former Etiometry CEO and Co-founder, Evan Butler, is taking on a new role as Chief Operating Officer.

About Etiometry

Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.

For more information, visit www.etiometry.com.